IL - 18在心血管疾病中的研究进展

www.yongyao.net　　2009-11-23 11:37:20　　来源：　　责任编辑：

分享到：

参　考　文　献
[ 1 ] Okamura H, Tstutsi H, Komatsui H, et al. Cloning of a new cytokine that induces IFN - γp roduction by T cell[ J ]. Nature, 1995, 378: 88- 91.
[ 2 ] Ushio S,NambaM,Okura T, et al. Cloning of the cDNA for human IFN - γinducing factor, exp ression in E. coil, and studies on the biologic activities of the p rotein [ J ]. Immunol, 1996, 156: 4274 -4279.
[ 3 ] Vermot - Desroches C, SubigerO, Guenot F, et al. Monoclonal antibodies specific for the IL - 18 recep tor [ J ]. Cell Immunol, 2005,236 (1 - 2) : 101 - 104.
[ 4 ] Wereszczynska - Siemiatkowska U, Kosel J, Siemiatkowski A. Biological p roperties of interleukin 18 [ J ]. PolMerkuriusz Lek, 2004,16 (93) : 279 - 281.
[ 5 ] GRACIEJ A, ROBER TSON S E,MCINNES I B. IL - 18 [ J ]. JLeukoc Biol, 2003, 73: 213 - 224
[ 6 ] 谢江娇,廖玉华,等. 兔动脉粥样硬化斑块内IL - 18表达的动态变化[ J ]. 中国分子心脏病学杂志, 2005, 5: 773 - 776.
[ 7 ] MALLAT Z, CORBAZA, SCOAZEC A, et al. Exp ression of IL - 18and the risk of CHD in European men: the p rospective ep idemiological study ofmyocardial infarction[ J ]. Circulation, 2003, 108: 2453- 2459.
[ 8 ] GUPTA S, PABLO AM, J IANGX, et al. IFN - gamma potentiates atherosclerosis in ApoE knock - out mice[ J ]. J Clin Invest, 1997,99: 2752 - 2761.
[ 9 ] WH ITMAN S C, RAV ISANKAR P,DaughertyA. IL - 18 enhances atherosclerosis in apolipop rp tein E ( - / - ) mice through release of interferon - gamma[ J ]. Circ Res, 2002, 90: 34 - 38.
[ 10 ] KOHNO K, KATAOKA,OHTSUKI T, et al. IGIF is a co - stimulatory factor on the activation of TH1 but not TH2 cells and exerts its effect independently of IL - 12 [ J ]. J Immunol, 1997, 158: 1541 -1550.
[ 11 ] SAHAR S, DWARAKANA TH RS, REDDYMAS, et al. AngiotensinⅡenhances IL - 18 mediated inflammatory gene exp ression in vascular smooth muscle cells: a novel cross - talk in the pathogenesis of atherosclerosis[ J ]. Circ Res, 2005, 96: 1064 - 1071.
[ 12 ] Akihiro, YTSugiyasu K, Toru T, et al. Interleukin一18 reduees exp ression of cardiac tumor necrosis factor - a and atrial nartiuretic PePtide in a murine model of viralmyocarditis[ J ]. Life Seienees,2002, 70: 1225 - 1234
[ 13 ] RonaldB. Smeltz, JuneChen, JnaeHu - Li. Regulation of IL - 18RecePtor Chain ExPression on CD4T Cells during THelPer( Th) l/Th2 [ J ]. J. of ExPerMed, 2001, 194 (16) : 143 - 153.
[ 14 ] 中华医学会儿科分会心血管组专家答疑. 心肌酶谱在病毒性心肌炎中的诊断作用[ J ]. 中国实用儿科杂志, 2000, 15 ( 5 ) :264.
[ 15 ] NeteaM, Fantuzzi, GKullbegrB, et al. Neutrolization of IL - 18 reduces neutroPhil tissue accumulation and Protection mice against lethal Eseheriehia Coli and Salmonella tyPhoymeerium endotoxemiaJ [ J ]. Imnmunol, 2000, 164: 2644 - 2649.
[ 16 ] Katsushi H, Haruyasu U, Shin - Ichiro K, et al. Il - 18 InducesA2cute BiPhasic Reduction in the Levels of CireulatingLeukoeytes in Miee[ J ]. Clin Immunol. 2002, (6) : 777 - 78.
[ 17 ] Patriek C, Georffey L. Vaeeinia Virus IL - 18 - Binding Protein PromotesVirulence by Reducing Gamma Interefron Production and Natuarl Killer and T - Cell Activity [ J ]. J. Virol. 2003, 77 ( 9 ) :990 - 996.
[ 18 ] M. Yamaoka - Tojo, T. Tojo, T. Inomata, et al. Circulating levels of IL - 18 reflect etiologies of heart failure: Thl/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure[ J ]. J Card Fail, 2002, 8: 21 - 27.
[ 19 ] ZiadMallat, et al. Evidence for altered IL - 18 pathway in human heart failure[ J ]. J FASEB, 2004, 9: 1 - 19.